首页 > 最新文献

Turkish Journal of Pathology最新文献

英文 中文
Granulomatous Mastitis: A Clinical and Diagnostic Dilemma. 肉芽肿性乳腺炎:临床和诊断的困境。
IF 1 Q4 PATHOLOGY Pub Date : 2022-01-01 DOI: 10.5146/tjpath.2021.01554
Emel Ebru Pala, Sumeyye Ekmekci, Melis Kilic, Ayberk Dursun, Gul Colakoglu, Cem Karaali, Mumin Emiroglu, Mustafa Emiroglu

Objective: Granulomatous mastitis (GM) is a challenging inflammatory disorder of the breast. In this study we aimed to present the detailed clinical and morphological features of GM cases, diagnostic clues for specific and idiopathic etiologies, the difficulties in evaluating trucut biopsies, and the results of different therapeutic approaches.

Material and method: We retrospectively analysed the clinical, radiological and morphological features of 114 GM cases diagnosed with fine needle aspiration, and trucut, incisional, and excisional biopsy.

Results: The mean age was 35.8. Only eight cases were older than 45 years. Bilateral involvement was observed in 4 (3.5%) cases. The most common clinical symptoms were breast mass/abscesses, tenderness, and skin changes. Microbiological culture was positive in 4 cases for gram-positive bacteria. Only 3 cases showed a positive tuberculin/PCR test for tuberculosis. The major USG finding was a hypoechoic well-defined or ill-defined mass/abscess; MRI finding was heterogeneous non-mass contrast enhancement. Cases diagnosed with cytology (35 cases) did not have breast malignancy either in their history or clinical follow up period. Fine needle aspiration cytology materials revealed epitheloid granulomas mixed with neutrophils, lymphocytes accompanied by giant cells, and suppurative necrosis. Histopathological reevaluation of 65 trucut/incisional/ excisional biopsies revealed granuloma formation in 65 (100%), Langhans type giant cells in 59 (90.7%), microabscess formation in 41 (63%), caseous necrosis in 1 (1.5%), neutrophilic cysts in 30 (46.1%), eosinophilic infiltration in 48 (73.8%), interlobular inflammation in 14 (21.5%), fat necrosis in 5 (7.6%), ductal ectasia in 6 (9.2%), and lactational changes in 4 (6.1%) cases. Granulomas were lobulocentric in 58 cases, foreign body type/fat necrosis-related in 6 case, and periductular in 1 case. Cystic neutrophilic granulomatous mastitis was observed in one case. We also evaluated the histochemical stains of these 65 biopsies. Only one sample was positive for acido-resistant bacilli (ARB) by the EZN method and one sample was positive for gram-positive bacilli by gram stain.

Conclusion: Small, superficial trucut biopsies may cause difficulties in determining the etiology and differential diagnosis of granulomatous mastitis. For optimal management and timing the appropriate therapy, the ideal biopsy procedure, special stains, and a multidisciplinary team consisting of the surgeon, pathologist, and radiologist are the most important issues.

目的:肉芽肿性乳腺炎(GM)是一种具有挑战性的乳腺炎性疾病。在这项研究中,我们旨在介绍GM病例的详细临床和形态学特征,特定和特发性病因的诊断线索,评估肿瘤活检的困难,以及不同治疗方法的结果。材料和方法:我们回顾性分析114例经细针穿刺诊断的GM病例的临床、放射学和形态学特征。结果:平均年龄35.8岁。年龄在45岁以上的只有8例。双侧受累4例(3.5%)。最常见的临床症状是乳房肿块/脓肿、压痛和皮肤变化。微生物培养革兰氏阳性菌4例。仅有3例结核杆菌素/PCR检测阳性。USG的主要发现是低回声、清晰或不明确的肿块/脓肿;MRI表现为非肿块增强。细胞学诊断的病例(35例)在病史或临床随访期间均无乳腺恶性肿瘤。细针吸细胞学检查显示上皮肉芽肿伴中性粒细胞,淋巴细胞伴巨细胞,化脓性坏死。对65例肿瘤活检进行组织病理学重新评估,发现肉芽肿65例(100%),朗汉斯巨细胞59例(90.7%),微脓肿41例(63%),干酪样坏死1例(1.5%),嗜中性粒细胞囊肿30例(46.1%),嗜酸性粒细胞浸润48例(73.8%),小叶间炎症14例(21.5%),脂肪坏死5例(7.6%),导管扩张6例(9.2%),泌乳改变4例(6.1%)。肉芽肿以小叶为中心58例,异物型/脂肪坏死相关6例,管周1例。囊性中性粒细胞肉芽肿性乳腺炎1例。我们还评估了这65例活检的组织化学染色。EZN法检测耐酸杆菌阳性1例,革兰氏染色检测革兰氏阳性杆菌阳性1例。结论:肉芽肿性乳腺炎的小的、浅表的组织活检可能给确定病因和鉴别诊断带来困难。对于最佳的管理和适当的治疗时机,理想的活检程序,特殊的染色,以及由外科医生,病理学家和放射科医生组成的多学科团队是最重要的问题。
{"title":"Granulomatous Mastitis: A Clinical and Diagnostic Dilemma.","authors":"Emel Ebru Pala,&nbsp;Sumeyye Ekmekci,&nbsp;Melis Kilic,&nbsp;Ayberk Dursun,&nbsp;Gul Colakoglu,&nbsp;Cem Karaali,&nbsp;Mumin Emiroglu,&nbsp;Mustafa Emiroglu","doi":"10.5146/tjpath.2021.01554","DOIUrl":"https://doi.org/10.5146/tjpath.2021.01554","url":null,"abstract":"<p><strong>Objective: </strong>Granulomatous mastitis (GM) is a challenging inflammatory disorder of the breast. In this study we aimed to present the detailed clinical and morphological features of GM cases, diagnostic clues for specific and idiopathic etiologies, the difficulties in evaluating trucut biopsies, and the results of different therapeutic approaches.</p><p><strong>Material and method: </strong>We retrospectively analysed the clinical, radiological and morphological features of 114 GM cases diagnosed with fine needle aspiration, and trucut, incisional, and excisional biopsy.</p><p><strong>Results: </strong>The mean age was 35.8. Only eight cases were older than 45 years. Bilateral involvement was observed in 4 (3.5%) cases. The most common clinical symptoms were breast mass/abscesses, tenderness, and skin changes. Microbiological culture was positive in 4 cases for gram-positive bacteria. Only 3 cases showed a positive tuberculin/PCR test for tuberculosis. The major USG finding was a hypoechoic well-defined or ill-defined mass/abscess; MRI finding was heterogeneous non-mass contrast enhancement. Cases diagnosed with cytology (35 cases) did not have breast malignancy either in their history or clinical follow up period. Fine needle aspiration cytology materials revealed epitheloid granulomas mixed with neutrophils, lymphocytes accompanied by giant cells, and suppurative necrosis. Histopathological reevaluation of 65 trucut/incisional/ excisional biopsies revealed granuloma formation in 65 (100%), Langhans type giant cells in 59 (90.7%), microabscess formation in 41 (63%), caseous necrosis in 1 (1.5%), neutrophilic cysts in 30 (46.1%), eosinophilic infiltration in 48 (73.8%), interlobular inflammation in 14 (21.5%), fat necrosis in 5 (7.6%), ductal ectasia in 6 (9.2%), and lactational changes in 4 (6.1%) cases. Granulomas were lobulocentric in 58 cases, foreign body type/fat necrosis-related in 6 case, and periductular in 1 case. Cystic neutrophilic granulomatous mastitis was observed in one case. We also evaluated the histochemical stains of these 65 biopsies. Only one sample was positive for acido-resistant bacilli (ARB) by the EZN method and one sample was positive for gram-positive bacilli by gram stain.</p><p><strong>Conclusion: </strong>Small, superficial trucut biopsies may cause difficulties in determining the etiology and differential diagnosis of granulomatous mastitis. For optimal management and timing the appropriate therapy, the ideal biopsy procedure, special stains, and a multidisciplinary team consisting of the surgeon, pathologist, and radiologist are the most important issues.</p>","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":"38 1","pages":"40-45"},"PeriodicalIF":1.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999696/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9687417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Role of Immunohistochemistry in the Differential Diagnosis of Pediatric Renal Tumors: Expression of Cyclin D1, Beta-Catenin , PDGFR-Alpha, and PTEN. 免疫组织化学在小儿肾肿瘤鉴别诊断中的作用:细胞周期蛋白D1、β -连环蛋白、pdgfr - α和PTEN的表达
IF 1 Q4 PATHOLOGY Pub Date : 2022-01-01 DOI: 10.5146/tjpath.2022.01568
Nuray Kepil, Şebnem Batur, Zeynep Ecem Kain, Gamze Özcan, Şenol Emre, Rahşan Özcan, Tülin Tiraje Celkan, Nil Çomunoğlu

Objective: Pediatric renal tumors overlap histomorphologically and may cause misdiagnosis. We aimed to determine the role of immunohistochemical staining of Cyclin D1, PTEN, beta-catenin and PDGFR-alpha on pediatric renal tumors.

Material and method: Thirty-six cases of 8 different tumors were included in the study. Four blocks of paraffin tissue microarray were constructed. Cyclin D1, PTEN, beta-catenin and PDGFR-alpha were used in all cases. Staining intensity and extent were graded.

Results: All cases of clear cell sarcoma (CCS) and epithelial components of Wilms tumor (WT) showed immunopositivity for Cyclin D1 but blastemal and stromal components of WT were negative. All cases of CCS and most cases of WT consisting of blastemal and stromal components demonstrated loss of expression with PTEN.

Conclusion: Cyclin D1 is not a specific immunohistochemical marker due to its strong and diffuse positivity in CCS cases. It may be useful to differentiate CCS from blastemal and stromal components of WT. Other markers except cyclin D1 do not have a role in the differential diagnosis.

目的:探讨小儿肾肿瘤的组织学重叠及易引起误诊的原因。我们的目的是确定免疫组化染色的Cyclin D1, PTEN, β -连环蛋白和pdgfr - α在儿童肾肿瘤中的作用。材料与方法:选取8种不同肿瘤36例进行研究。构建了4块石蜡组织芯片。所有病例均使用Cyclin D1、PTEN、β -连环蛋白和pdgfr - α。对染色强度和程度进行分级。结果:所有透明细胞肉瘤(CCS)和Wilms肿瘤(WT)上皮成分均显示Cyclin D1免疫阳性,而WT的胚质成分和基质成分均为阴性。所有的CCS病例和大多数由胚质和基质组成的WT病例都表现出PTEN的表达缺失。结论:Cyclin D1在CCS病例中呈强弥漫性阳性,不是特异性免疫组织化学标志物。这可能有助于将CCS与WT的胚质和基质成分区分开来。除了细胞周期蛋白D1外,其他标志物在鉴别诊断中没有作用。
{"title":"Role of Immunohistochemistry in the Differential Diagnosis of Pediatric Renal Tumors: Expression of Cyclin D1, Beta-Catenin , PDGFR-Alpha, and PTEN.","authors":"Nuray Kepil,&nbsp;Şebnem Batur,&nbsp;Zeynep Ecem Kain,&nbsp;Gamze Özcan,&nbsp;Şenol Emre,&nbsp;Rahşan Özcan,&nbsp;Tülin Tiraje Celkan,&nbsp;Nil Çomunoğlu","doi":"10.5146/tjpath.2022.01568","DOIUrl":"https://doi.org/10.5146/tjpath.2022.01568","url":null,"abstract":"<p><strong>Objective: </strong>Pediatric renal tumors overlap histomorphologically and may cause misdiagnosis. We aimed to determine the role of immunohistochemical staining of Cyclin D1, PTEN, beta-catenin and PDGFR-alpha on pediatric renal tumors.</p><p><strong>Material and method: </strong>Thirty-six cases of 8 different tumors were included in the study. Four blocks of paraffin tissue microarray were constructed. Cyclin D1, PTEN, beta-catenin and PDGFR-alpha were used in all cases. Staining intensity and extent were graded.</p><p><strong>Results: </strong>All cases of clear cell sarcoma (CCS) and epithelial components of Wilms tumor (WT) showed immunopositivity for Cyclin D1 but blastemal and stromal components of WT were negative. All cases of CCS and most cases of WT consisting of blastemal and stromal components demonstrated loss of expression with PTEN.</p><p><strong>Conclusion: </strong>Cyclin D1 is not a specific immunohistochemical marker due to its strong and diffuse positivity in CCS cases. It may be useful to differentiate CCS from blastemal and stromal components of WT. Other markers except cyclin D1 do not have a role in the differential diagnosis.</p>","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":"38 2","pages":"83-89"},"PeriodicalIF":1.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9702444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease. DUX4在骨髓中的表达分析及对DUX4健康和疾病功能的再探讨。
IF 1 Q4 PATHOLOGY Pub Date : 2022-01-01 DOI: 10.5146/tjpath.2021.01564
Ceren Hangul, Oznur Tokta, Sibel Berker Karauzum, Bahar Akkaya, Hulya Yildirim, Funda Tayfun Kupesiz, Ayse Nur Akinel

Objective: DUX4 is an embryonic transcription factor (TF) later silenced in somatic tissues, while active in germline testis cells. Re-expression in somatic cells has been revealed to be present in pathologic conditions such as dystrophy, leukemia, and other cancer types. Embryonic cells, cancer cells and testis cells that show DUX4 expression are pluri-multipotent cells. This lead us to question "Could DUX4 be a TF that is active in certain types of potent somatic cells?" As a perfect reflection of the potent cell pool, we aimed to reveal DUX4 expression in the bone marrow.

Material and method: Bone marrow aspiration materials of seven healthy donors aged between 3 and 32 (2 males/5 females) were investigated with qPCR analysis after RNA isolation for the presence of DUX4 full length mRNA expression. Samples have been investigated for protein existence of DUX4 via immunohistochemistry in two donors that had sufficient aspiration material.

Results: DUX4 mRNA expression was present in all donors, with higher expression compared to B-actin. DUX4 positive stained cells were also detected by immunohistochemistry.

Conclusion: With these results, novel expression for DUX4 in hematopoietic tissue is described. Further studies on the function of DUX4 in hematopoietic cells can shed light on DUX4-related pathways, and contribute to the treatment of DUX4-related diseases such as B-ALL, other cancers, and facioscapulohumeral muscular dystrophy.

目的:DUX4是一种胚胎转录因子(TF),后来在体细胞组织中沉默,但在生殖系睾丸细胞中具有活性。体细胞中的再表达已被发现存在于病理条件下,如营养不良、白血病和其他癌症类型。显示DUX4表达的胚胎细胞、癌症细胞和睾丸细胞是多能干细胞。这让我们产生了一个问题:“DUX4可能是一种在某些类型的强效体细胞中具有活性的TF吗?”作为强效细胞库的完美反映,我们旨在揭示DUX4在骨髓中的表达。材料和方法:在RNA分离后,用qPCR分析对7名年龄在3至32岁之间的健康捐献者(2名男性/5名女性)的骨髓抽吸材料进行DUX4全长mRNA表达的研究。已经通过免疫组织化学在具有足够抽吸材料的两个供体中研究了样品中DUX4的蛋白质存在。结果:DUX4 mRNA在所有供体中均有表达,与B-肌动蛋白相比表达更高。免疫组化法检测DUX4阳性染色细胞。结论:利用这些结果,描述了DUX4在造血组织中的新表达。对DUX4在造血细胞中的功能的进一步研究可以阐明DUX4相关途径,并有助于治疗DUX4相关性疾病,如B-ALL、其他癌症和面肩肱肌营养不良。
{"title":"Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease.","authors":"Ceren Hangul,&nbsp;Oznur Tokta,&nbsp;Sibel Berker Karauzum,&nbsp;Bahar Akkaya,&nbsp;Hulya Yildirim,&nbsp;Funda Tayfun Kupesiz,&nbsp;Ayse Nur Akinel","doi":"10.5146/tjpath.2021.01564","DOIUrl":"10.5146/tjpath.2021.01564","url":null,"abstract":"<p><strong>Objective: </strong>DUX4 is an embryonic transcription factor (TF) later silenced in somatic tissues, while active in germline testis cells. Re-expression in somatic cells has been revealed to be present in pathologic conditions such as dystrophy, leukemia, and other cancer types. Embryonic cells, cancer cells and testis cells that show DUX4 expression are pluri-multipotent cells. This lead us to question \"Could DUX4 be a TF that is active in certain types of potent somatic cells?\" As a perfect reflection of the potent cell pool, we aimed to reveal DUX4 expression in the bone marrow.</p><p><strong>Material and method: </strong>Bone marrow aspiration materials of seven healthy donors aged between 3 and 32 (2 males/5 females) were investigated with qPCR analysis after RNA isolation for the presence of DUX4 full length mRNA expression. Samples have been investigated for protein existence of DUX4 via immunohistochemistry in two donors that had sufficient aspiration material.</p><p><strong>Results: </strong>DUX4 mRNA expression was present in all donors, with higher expression compared to B-actin. DUX4 positive stained cells were also detected by immunohistochemistry.</p><p><strong>Conclusion: </strong>With these results, novel expression for DUX4 in hematopoietic tissue is described. Further studies on the function of DUX4 in hematopoietic cells can shed light on DUX4-related pathways, and contribute to the treatment of DUX4-related diseases such as B-ALL, other cancers, and facioscapulohumeral muscular dystrophy.</p>","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":"38 3","pages":"219-226"},"PeriodicalIF":1.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39773286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causes of Granulomatous Inflammation in Native and Allograft Kidneys: Case Series from A Single Center and A Review of the Literature. 原生肾脏和同种异体移植肾脏肉芽肿性炎症的原因:来自单一中心的病例系列和文献综述。
IF 1 Q4 PATHOLOGY Pub Date : 2022-01-01 DOI: 10.5146/tjpath.2021.01561
Cihan Heybeli, Berna Demir Yuksel, Mehtat Unlu, Mehmet Ası Oktan, Hayri Ustun Arda, Ozcan Uzun, Filiz Yildirim, Serkan Yildiz, Caner Cavdar, Aykut Sifil, Ali Celik, Sulen Sarioglu

Objective: Granulomatous interstitial nephritis is a rare finding, and etiology differs by geography. We aimed to investigate the distribution of causes of granuloma/granulomata in the kidney and renal survival of these patients in a tertiary care hospital in Western Turkey.

Material and method: Medical records of adults who underwent a kidney biopsy procedure in our institution between January 2000 and June 2019 were reviewed. Pathology reports were searched for biopsies where a granuloma was identified.

Results: Nineteen of 1121 (1.7%) kidney biopsies included granuloma, 17 in native kidneys, and 2 in transplants. The majority of indications for native kidney biopsy was a rise in serum creatinine. Etiologies of granuloma included the following: pauci-immune vasculitis (n=11, 64.7%), tuberculosis (n=2, 11.8%), drug-induced (n=2, 11.8%), tubulointerstitial nephritis/uveitis (TINU) syndrome (n=1, 5.9%), and systemic-lupus erythematosus (n=1, 5.9%). Despite treatment, 6 of 11 (54.5%) patients with vasculitis developed end-stage kidney disease (ESKD) during the median follow-up of 16 months. Both of the patients with tuberculosis, and the patient with TINU syndrome developed ESKD months after the kidney biopsy, despite appropriate therapies. The only case with drug-induced granuloma and both cases with allograft kidney granuloma responded well to glucocorticoids, achieving a complete renal recovery.

Conclusion: The majority of our series had granuloma in the kidney secondary to vasculitis and renal outcomes appear considerably unfavorable despite treatment, probably related to the primary diagnosis. Multicenter studies are needed to better determine the etiology and outcome of each granuloma etiology at different geographic locations.

目的:肉芽肿性间质性肾炎是一种罕见的疾病,其病因因地域而异。我们的目的是调查肾脏肉芽肿/肉芽肿的原因分布和这些患者在土耳其西部三级保健医院的肾脏生存。材料和方法:回顾了2000年1月至2019年6月期间在我们机构接受肾活检手术的成年人的医疗记录。病理报告中查找了肉芽肿的活检。结果:1121例肾活检中有19例(1.7%)包括肉芽肿,17例来自原生肾脏,2例来自移植肾脏。大多数原生肾活检的适应症是血清肌酐升高。肉芽肿的病因包括:少免疫血管炎(n=11, 64.7%)、结核(n=2, 11.8%)、药物诱导(n=2, 11.8%)、肾小管间质性肾炎/葡萄膜炎(TINU)综合征(n=1, 5.9%)和系统性红斑狼疮(n=1, 5.9%)。尽管接受了治疗,11例血管炎患者中有6例(54.5%)在中位随访16个月期间发展为终末期肾病(ESKD)。尽管接受了适当的治疗,但结核患者和TINU综合征患者在肾活检后数月仍发生ESKD。唯一一例药物性肉芽肿和两例同种异体肾移植肉芽肿对糖皮质激素反应良好,肾脏完全恢复。结论:我们研究的大多数患者继发于血管炎的肾脏肉芽肿,尽管接受了治疗,但肾脏预后相当不利,这可能与最初的诊断有关。需要多中心研究来更好地确定不同地理位置的每种肉芽肿病因的病因和结果。
{"title":"Causes of Granulomatous Inflammation in Native and Allograft Kidneys: Case Series from A Single Center and A Review of the Literature.","authors":"Cihan Heybeli,&nbsp;Berna Demir Yuksel,&nbsp;Mehtat Unlu,&nbsp;Mehmet Ası Oktan,&nbsp;Hayri Ustun Arda,&nbsp;Ozcan Uzun,&nbsp;Filiz Yildirim,&nbsp;Serkan Yildiz,&nbsp;Caner Cavdar,&nbsp;Aykut Sifil,&nbsp;Ali Celik,&nbsp;Sulen Sarioglu","doi":"10.5146/tjpath.2021.01561","DOIUrl":"https://doi.org/10.5146/tjpath.2021.01561","url":null,"abstract":"<p><strong>Objective: </strong>Granulomatous interstitial nephritis is a rare finding, and etiology differs by geography. We aimed to investigate the distribution of causes of granuloma/granulomata in the kidney and renal survival of these patients in a tertiary care hospital in Western Turkey.</p><p><strong>Material and method: </strong>Medical records of adults who underwent a kidney biopsy procedure in our institution between January 2000 and June 2019 were reviewed. Pathology reports were searched for biopsies where a granuloma was identified.</p><p><strong>Results: </strong>Nineteen of 1121 (1.7%) kidney biopsies included granuloma, 17 in native kidneys, and 2 in transplants. The majority of indications for native kidney biopsy was a rise in serum creatinine. Etiologies of granuloma included the following: pauci-immune vasculitis (n=11, 64.7%), tuberculosis (n=2, 11.8%), drug-induced (n=2, 11.8%), tubulointerstitial nephritis/uveitis (TINU) syndrome (n=1, 5.9%), and systemic-lupus erythematosus (n=1, 5.9%). Despite treatment, 6 of 11 (54.5%) patients with vasculitis developed end-stage kidney disease (ESKD) during the median follow-up of 16 months. Both of the patients with tuberculosis, and the patient with TINU syndrome developed ESKD months after the kidney biopsy, despite appropriate therapies. The only case with drug-induced granuloma and both cases with allograft kidney granuloma responded well to glucocorticoids, achieving a complete renal recovery.</p><p><strong>Conclusion: </strong>The majority of our series had granuloma in the kidney secondary to vasculitis and renal outcomes appear considerably unfavorable despite treatment, probably related to the primary diagnosis. Multicenter studies are needed to better determine the etiology and outcome of each granuloma etiology at different geographic locations.</p>","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":"38 2","pages":"122-132"},"PeriodicalIF":1.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999700/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9337567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pleomorphic Adenoma of Breast: Report of Two Cases, One in A Male Patient. 乳腺多形性腺瘤2例报告,男1例。
IF 1 Q4 PATHOLOGY Pub Date : 2022-01-01 DOI: 10.5146/tjpath.2021.01543
Orwa Elaiwy, Khaled Al-Sawalmeh, Hayan Abo Samra, Abdulrazzaq Haider, Mohammed Akhtar

Pleomorphic adenoma of breast (PAB) is a rare mammary tumor of a mixed epithelial-myoepithelial nature. We report two patients with PAB, one of which is male. We believe our male patient is the sixth case of PAB in male breast in the literature. The two cases expressed heterogeneous clinical and radiological characteristics while showing similar histology and immunohistochemical staining profile. The first case was managed with surgical resection while the second underwent interventional radiology excision. PAB is usually a benign entity with occasional cases of recurrence. Malignant transformation is rare but has been reported in a few cases.

乳腺多形性腺瘤(PAB)是一种罕见的上皮-肌上皮混合性质的乳腺肿瘤。我们报告了两例PAB患者,其中一名是男性。我们相信我们的男性患者是文献中第6例男性乳房PAB病例。这两个病例表现出不同的临床和放射学特征,但表现出相似的组织学和免疫组织化学染色谱。第一例手术切除,第二例行介入放射学切除。PAB通常为良性,偶有复发。恶性转化是罕见的,但已报道在少数情况下。
{"title":"Pleomorphic Adenoma of Breast: Report of Two Cases, One in A Male Patient.","authors":"Orwa Elaiwy,&nbsp;Khaled Al-Sawalmeh,&nbsp;Hayan Abo Samra,&nbsp;Abdulrazzaq Haider,&nbsp;Mohammed Akhtar","doi":"10.5146/tjpath.2021.01543","DOIUrl":"https://doi.org/10.5146/tjpath.2021.01543","url":null,"abstract":"<p><p>Pleomorphic adenoma of breast (PAB) is a rare mammary tumor of a mixed epithelial-myoepithelial nature. We report two patients with PAB, one of which is male. We believe our male patient is the sixth case of PAB in male breast in the literature. The two cases expressed heterogeneous clinical and radiological characteristics while showing similar histology and immunohistochemical staining profile. The first case was managed with surgical resection while the second underwent interventional radiology excision. PAB is usually a benign entity with occasional cases of recurrence. Malignant transformation is rare but has been reported in a few cases.</p>","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":"38 2","pages":"153-157"},"PeriodicalIF":1.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999686/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9325317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Detection of ALK Gene Rearrangements in Non-Small Cell Lung Cancer by Immunocytochemistry and Fluorescence in Situ Hybridization on Cytologic Samples. 免疫细胞化学和荧光原位杂交检测非小细胞肺癌中ALK基因重排。
IF 1 Q4 PATHOLOGY Pub Date : 2022-01-01 DOI: 10.5146/tjpath.2021.01542
Suneel Rachagiri, Parikshaa Gupta, Nalini Gupta, Manish Rohilla, Navneet Singh, Arvind Rajwanshi

Objective: Determination of the molecular status is mandatory for personalized treatment of patients with non-small cell lung carcinoma. The present study was performed to detect anaplastic lymphoma kinase (ALK) rearrangements in pulmonary adenocarcinoma on cytology samples, using immunocytochemistry (ICC) and fluorescence in situ hybridization (FISH) on cell-blocks to assess the diagnostic reliability of these two techniques.

Material and method: A total of 50 confirmed lung adenocarcinoma cases were included. In all the 50 cases, ICC was performed for ALK protein expression by using the D5F3 clone on Ventana platform. On the basis of ALK protein expression on ICC, the cases were categorized as ALK positive (2+ or 3+ strong cytoplasmic granular positivity) or negative (negative or 1+ cytoplasmic granular positivity). FISH for detection of ALK gene rearrangement was performed in 7 ALK ICC positive cases and 7 ALK ICC negative cases using the Vysis ALK break apart FISH probe kit.

Results: Based on ICC, 7(14%) cases were ALK positive and 43(86%) were ALK negative. ALK gene rearrangements in lung adenocarcinoma were more commonly seen in non-smokers (31.25%) as compared to smokers (6.25%). Among the ALK-ICC positive cases, FISH demonstrated break apart signal in 5 cases (ALK- ICC positive); however, no break-apart signals were seen in 2 ALK-ICC positive and all the seven ALK-ICC negative cases.

Conclusion: Immunocytochemistry on cell- blocks using DF53 clone is a highly sensitive and specific method for the detection of ALK gene rearrangements in lung adenocarcinoma with a greater number of ALK positive cases being detected on ICC as compared to the ALK-FISH.

目的:对非小细胞肺癌患者进行分子状态检测,对其个性化治疗具有重要意义。本研究在细胞学样本上检测肺腺癌间变性淋巴瘤激酶(ALK)重排,使用细胞块上的免疫细胞化学(ICC)和荧光原位杂交(FISH)来评估这两种技术的诊断可靠性。材料与方法:共纳入50例确诊肺腺癌病例。在所有50例中,利用D5F3克隆在Ventana平台上进行了ALK蛋白的ICC表达。根据ICC上ALK蛋白的表达情况,将病例分为ALK阳性(2+或3+强胞质颗粒阳性)和阴性(1+或阴性胞质颗粒阳性)。采用Vysis ALK break apart FISH探针试剂盒对7例ALK ICC阳性和7例ALK ICC阴性病例进行了ALK基因重排检测。结果:基于ICC, ALK阳性7例(14%),ALK阴性43例(86%)。肺腺癌中ALK基因重排在非吸烟者(31.25%)中较吸烟者(6.25%)更为常见。在ALK-ICC阳性的5例中,FISH表现出分离信号(ALK- ICC阳性);然而,2例ALK-ICC阳性和7例ALK-ICC阴性均未见分离信号。结论:利用DF53克隆在细胞块上免疫细胞化学检测肺腺癌中ALK基因重排是一种高度敏感和特异性的方法,与ALK- fish相比,ICC检测到的ALK阳性病例数量更多。
{"title":"Detection of ALK Gene Rearrangements in Non-Small Cell Lung Cancer by Immunocytochemistry and Fluorescence in Situ Hybridization on Cytologic Samples.","authors":"Suneel Rachagiri,&nbsp;Parikshaa Gupta,&nbsp;Nalini Gupta,&nbsp;Manish Rohilla,&nbsp;Navneet Singh,&nbsp;Arvind Rajwanshi","doi":"10.5146/tjpath.2021.01542","DOIUrl":"https://doi.org/10.5146/tjpath.2021.01542","url":null,"abstract":"<p><strong>Objective: </strong>Determination of the molecular status is mandatory for personalized treatment of patients with non-small cell lung carcinoma. The present study was performed to detect anaplastic lymphoma kinase (ALK) rearrangements in pulmonary adenocarcinoma on cytology samples, using immunocytochemistry (ICC) and fluorescence in situ hybridization (FISH) on cell-blocks to assess the diagnostic reliability of these two techniques.</p><p><strong>Material and method: </strong>A total of 50 confirmed lung adenocarcinoma cases were included. In all the 50 cases, ICC was performed for ALK protein expression by using the D5F3 clone on Ventana platform. On the basis of ALK protein expression on ICC, the cases were categorized as ALK positive (2+ or 3+ strong cytoplasmic granular positivity) or negative (negative or 1+ cytoplasmic granular positivity). FISH for detection of ALK gene rearrangement was performed in 7 ALK ICC positive cases and 7 ALK ICC negative cases using the Vysis ALK break apart FISH probe kit.</p><p><strong>Results: </strong>Based on ICC, 7(14%) cases were ALK positive and 43(86%) were ALK negative. ALK gene rearrangements in lung adenocarcinoma were more commonly seen in non-smokers (31.25%) as compared to smokers (6.25%). Among the ALK-ICC positive cases, FISH demonstrated break apart signal in 5 cases (ALK- ICC positive); however, no break-apart signals were seen in 2 ALK-ICC positive and all the seven ALK-ICC negative cases.</p><p><strong>Conclusion: </strong>Immunocytochemistry on cell- blocks using DF53 clone is a highly sensitive and specific method for the detection of ALK gene rearrangements in lung adenocarcinoma with a greater number of ALK positive cases being detected on ICC as compared to the ALK-FISH.</p>","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":"38 1","pages":"16-24"},"PeriodicalIF":1.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9331566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calreticulin Immunohistochemistry in Myeloproliferative Neoplasms - Evolution of a New Cost-Effective Diagnostic Tool: A Retrospective Study with Histological and Molecular Correlation. 骨髓增生性肿瘤中的钙网蛋白免疫组化-一种新的成本效益诊断工具的发展:组织学和分子相关性的回顾性研究。
IF 1 Q4 PATHOLOGY Pub Date : 2022-01-01 DOI: 10.5146/tjpath.2021.01550
Sanjeet Roy, Marie Therese Manipadam, Poonkuzhali Balasubramanian

Objective: Recent WHO 2017 guidelines mandates mutational analysis for the diagnosis of myeloproliferative disorders (MPN). JAK2V617F has been found in only 50-60% of Primary myelofibrosis (PMF) and Essential thrombocythaemia (ET). A recently discovered somatic Calreticulin (CALR) mutation has been linked to MPN. This mutation leads to a common 36 amino acid C-terminus that can be detected accurately by immunohistochemistry (IHC). Limited published literature exists on the utility of CAL2IHC as a diagnostic tool. The study aimed to validate the sensitivity and specificity of CAL2IHC for its use as a cost effective and rapid diagnostic tool.

Material and method: Subjects included 23 patients of MPN (15 PMF, 6 ET, 2 PV (Polycythaemia Vera)), diagnosed between January 2014 to November 2016 with adequate available tissue for histopathological and mutational analysis. Mutational analysis had been performed with Bidirectional Sanger sequencing. CAL2IHC was performed in all cases and the sensitivity and specificity of CAL2 IHC to identify the Calreticulin mutation was evaluated with respect to comparison with the gold standard mutation analysis.

Results: In the 23 MPN patients, CAL2 IHC detected CALR mutation with a sensitivity of 95% and a specificity of 100%. Both cases of PV were negative for CAL2IHC. CAL2IHC showed cytoplasmic positivity in ET (2-3+) and PMF (1-3+) with (62-69%) positive megakaryocyte staining. All 6 ET cases and all 14/15 PMF cases were CAL2IHC positive, and these results were concordant with CALR mutational analysis.

Conclusion: Anti-CAL2 immunohistochemistry is a specific and a sensitive marker to detect CALR mutation. Its' cost effectiveness and fast results are quite advantageous as compared to molecular analysis.

目的:世卫组织2017年最新指南要求对骨髓增生性疾病(MPN)进行突变分析诊断。JAK2V617F仅在50-60%的原发性骨髓纤维化(PMF)和原发性血小板血症(ET)中被发现。最近发现的体细胞钙网蛋白(CALR)突变与MPN有关。这种突变导致一个常见的36个氨基酸的c端,可以通过免疫组织化学(IHC)准确检测。关于CAL2IHC作为诊断工具的应用,已发表的文献有限。该研究旨在验证CAL2IHC作为一种经济有效的快速诊断工具的敏感性和特异性。材料和方法:研究对象包括2014年1月至2016年11月诊断的23例MPN患者(PMF 15例,ET 6例,PV 2例),有足够的可用组织进行组织病理学和突变分析。采用双向Sanger测序进行突变分析。所有病例均进行CAL2IHC检测,并与金标准突变分析进行比较,评估CAL2IHC检测钙网蛋白突变的敏感性和特异性。结果:在23例MPN患者中,CAL2 IHC检测CALR突变的敏感性为95%,特异性为100%。两例PV均为CAL2IHC阴性。CAL2IHC显示ET(2-3+)和PMF(1-3+)细胞质阳性,巨核细胞染色(62-69%)阳性。6例ET和14/15例PMF均为CAL2IHC阳性,与CALR突变分析结果一致。结论:抗cal2免疫组化是检测CALR突变的特异性、敏感性标志物。与分子分析相比,其成本效益和快速结果具有很大优势。
{"title":"Calreticulin Immunohistochemistry in Myeloproliferative Neoplasms - Evolution of a New Cost-Effective Diagnostic Tool: A Retrospective Study with Histological and Molecular Correlation.","authors":"Sanjeet Roy,&nbsp;Marie Therese Manipadam,&nbsp;Poonkuzhali Balasubramanian","doi":"10.5146/tjpath.2021.01550","DOIUrl":"https://doi.org/10.5146/tjpath.2021.01550","url":null,"abstract":"<p><strong>Objective: </strong>Recent WHO 2017 guidelines mandates mutational analysis for the diagnosis of myeloproliferative disorders (MPN). JAK2V617F has been found in only 50-60% of Primary myelofibrosis (PMF) and Essential thrombocythaemia (ET). A recently discovered somatic Calreticulin (CALR) mutation has been linked to MPN. This mutation leads to a common 36 amino acid C-terminus that can be detected accurately by immunohistochemistry (IHC). Limited published literature exists on the utility of CAL2IHC as a diagnostic tool. The study aimed to validate the sensitivity and specificity of CAL2IHC for its use as a cost effective and rapid diagnostic tool.</p><p><strong>Material and method: </strong>Subjects included 23 patients of MPN (15 PMF, 6 ET, 2 PV (Polycythaemia Vera)), diagnosed between January 2014 to November 2016 with adequate available tissue for histopathological and mutational analysis. Mutational analysis had been performed with Bidirectional Sanger sequencing. CAL2IHC was performed in all cases and the sensitivity and specificity of CAL2 IHC to identify the Calreticulin mutation was evaluated with respect to comparison with the gold standard mutation analysis.</p><p><strong>Results: </strong>In the 23 MPN patients, CAL2 IHC detected CALR mutation with a sensitivity of 95% and a specificity of 100%. Both cases of PV were negative for CAL2IHC. CAL2IHC showed cytoplasmic positivity in ET (2-3+) and PMF (1-3+) with (62-69%) positive megakaryocyte staining. All 6 ET cases and all 14/15 PMF cases were CAL2IHC positive, and these results were concordant with CALR mutational analysis.</p><p><strong>Conclusion: </strong>Anti-CAL2 immunohistochemistry is a specific and a sensitive marker to detect CALR mutation. Its' cost effectiveness and fast results are quite advantageous as compared to molecular analysis.</p>","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":"38 1","pages":"25-33"},"PeriodicalIF":1.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9331567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hepatocellular Carcinomas with Granulomatous Inflammation In Tumor Stroma: Clinicopathologic Characteristics. 肝细胞癌伴间质肉芽肿性炎症:临床病理特征。
IF 1 Q4 PATHOLOGY Pub Date : 2022-01-01 DOI: 10.5146/tjpath.2021.01562
Burcu Saka, Ferhat Ozden, Ayse Armutlu, Gokhan Ertugrul
Objective: To determine the frequency of granulomatous inflammation within hepatocellular carcinoma (HCC) and its clinicopathologic associations. Material and Method: Fifty-eight HCCs (51 explants, 3 lobectomies, and 4 segmentectomies) were reviewed. Results: Five (8.6%) cases (F/M=1/4, mean age: 63.6) were identified with granulomas.1/5 had history of neoadjuvant therapy. 4/5 patients presented with early stage (pT1/2). All were well-differentiated (Grade1-2/4). The mean number of tumor foci was 3.6, with a median size of 2.2 cm. All of them had advanced fibrosis. No difference was identified from cases without granulomas (n=53) in terms of prognosis and aforementioned parameters (p> 0.05). Granulomas were mainly concentrated in peripheral parts of the tumors. One case with nodule-in-nodule formation had granulomas lined along the border of the inner nodule. In 2 cases, granulomas were identified in steatohepatitic areas, while another had clear cell change. Only 1 had necrotizing granulomas, none with acid resistant bacilli. Two cases revealed concomitant granulomas in the adjacent liver parenchyma in addition to the tumor stroma. Except for one with a history of tuberculosis, none of the cases had a granulomatous disease. Conclusion: This is the largest case series of HCCs with granulomas by far. Our data revealed neither clinicopathologic and prognostic difference nor definite etiology related to granulomas. Yet, association with steatotic and clear tumor cells suggests the role of cytoplasmic content, while distribution of granulomas points to host immune response.
目的:探讨肝细胞癌(HCC)肉芽肿性炎症的发生频率及其与临床病理的关系。材料和方法:回顾了58例hcc(51例外植体,3例肺叶切除术,4例节段切除术)。结果:确诊肉芽肿5例(8.6%),F/M=1/4,平均年龄63.6岁。1/5有新辅助治疗史。4/5患者表现为早期(pT1/2)。均为高分化(1-2/4级)。平均3.6个肿瘤灶,中位大小为2.2 cm。他们都患有晚期纤维化。与非肉芽肿患者(n=53)在预后及上述参数方面无差异(p > 0.05)。肉芽肿主要集中在肿瘤周围。1例结节内形成肉芽肿,肉芽肿沿内结节边缘排列。2例在脂肪性肝区发现肉芽肿,另1例有明显的细胞改变。仅有1例坏死性肉芽肿,无耐酸杆菌。除肿瘤间质外,2例相邻肝实质同时有肉芽肿。除1例有结核病史外,其余病例均无肉芽肿性疾病。结论:这是迄今为止最大的hcc合并肉芽肿病例系列。我们的资料既没有显示肉芽肿的临床病理和预后差异,也没有明确的病因。然而,与脂肪变性和透明肿瘤细胞的关联提示细胞质含量的作用,而肉芽肿的分布提示宿主免疫应答。
{"title":"Hepatocellular Carcinomas with Granulomatous Inflammation In Tumor Stroma: Clinicopathologic Characteristics.","authors":"Burcu Saka,&nbsp;Ferhat Ozden,&nbsp;Ayse Armutlu,&nbsp;Gokhan Ertugrul","doi":"10.5146/tjpath.2021.01562","DOIUrl":"https://doi.org/10.5146/tjpath.2021.01562","url":null,"abstract":"Objective: To determine the frequency of granulomatous inflammation within hepatocellular carcinoma (HCC) and its clinicopathologic associations. Material and Method: Fifty-eight HCCs (51 explants, 3 lobectomies, and 4 segmentectomies) were reviewed. Results: Five (8.6%) cases (F/M=1/4, mean age: 63.6) were identified with granulomas.1/5 had history of neoadjuvant therapy. 4/5 patients presented with early stage (pT1/2). All were well-differentiated (Grade1-2/4). The mean number of tumor foci was 3.6, with a median size of 2.2 cm. All of them had advanced fibrosis. No difference was identified from cases without granulomas (n=53) in terms of prognosis and aforementioned parameters (p> 0.05). Granulomas were mainly concentrated in peripheral parts of the tumors. One case with nodule-in-nodule formation had granulomas lined along the border of the inner nodule. In 2 cases, granulomas were identified in steatohepatitic areas, while another had clear cell change. Only 1 had necrotizing granulomas, none with acid resistant bacilli. Two cases revealed concomitant granulomas in the adjacent liver parenchyma in addition to the tumor stroma. Except for one with a history of tuberculosis, none of the cases had a granulomatous disease. Conclusion: This is the largest case series of HCCs with granulomas by far. Our data revealed neither clinicopathologic and prognostic difference nor definite etiology related to granulomas. Yet, association with steatotic and clear tumor cells suggests the role of cytoplasmic content, while distribution of granulomas points to host immune response.","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":"38 2","pages":"133-141"},"PeriodicalIF":1.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999682/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9332941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. 世界卫生组织牙源性病变分类:2022(5)版变化总结
IF 1 Q4 PATHOLOGY Pub Date : 2022-01-01 DOI: 10.5146/tjpath.2022.01573
Merva Soluk-Tekkesin, John M Wright

The 5th edition of the World Health Organization (WHO) Classification of Head and Neck Tumors opened to online access in March 2022. This edition is conceptually similar to the previous classification of odontogenic lesions. The only newly defined entity in odontogenic lesions is adenoid ameloblastoma, which is classified under benign epithelial odontogenic tumors. While not odontogenic, the surgical ciliated cyst is a new entry to the cyst classification of the jaws. In other respects, a very important change was made in the new blue books that added 'essential and desirable diagnostic criteria' for each entity to highlight the features considered indispensable for diagnosis. In this article, we review the odontogenic tumors and cysts of the jaw sections of the Odontogenic and Maxillofacial Bone Tumors Chapter, outlining changes from the 2017 WHO classification and summarizing the essential diagnostic criteria and new developments.

世界卫生组织(世卫组织)第五版头颈部肿瘤分类于2022年3月开放在线访问。这个版本在概念上类似于以前的牙源性病变分类。在牙源性病变中唯一新定义的实体是腺样成釉细胞瘤,它被归类为良性上皮性牙源性肿瘤。虽然不是牙源性的,但外科纤毛囊肿是颌骨囊肿分类的新条目。在其他方面,在新的蓝皮书中做了一个非常重要的改变,为每个实体增加了“必要和理想的诊断标准”,以突出被认为是诊断不可或缺的特征。在本文中,我们回顾了牙源性和颌面骨肿瘤章节中颌骨部分的牙源性肿瘤和囊肿,概述了2017年WHO分类的变化,并总结了基本诊断标准和新进展。
{"title":"The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition.","authors":"Merva Soluk-Tekkesin,&nbsp;John M Wright","doi":"10.5146/tjpath.2022.01573","DOIUrl":"https://doi.org/10.5146/tjpath.2022.01573","url":null,"abstract":"<p><p>The 5th edition of the World Health Organization (WHO) Classification of Head and Neck Tumors opened to online access in March 2022. This edition is conceptually similar to the previous classification of odontogenic lesions. The only newly defined entity in odontogenic lesions is adenoid ameloblastoma, which is classified under benign epithelial odontogenic tumors. While not odontogenic, the surgical ciliated cyst is a new entry to the cyst classification of the jaws. In other respects, a very important change was made in the new blue books that added 'essential and desirable diagnostic criteria' for each entity to highlight the features considered indispensable for diagnosis. In this article, we review the odontogenic tumors and cysts of the jaw sections of the Odontogenic and Maxillofacial Bone Tumors Chapter, outlining changes from the 2017 WHO classification and summarizing the essential diagnostic criteria and new developments.</p>","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":"38 2","pages":"168-184"},"PeriodicalIF":1.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999699/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9333444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 36
Laryngeal Chondrosarcoma of the Thyroid Cartilage. 甲状腺软骨的喉软骨肉瘤。
IF 1 Q4 PATHOLOGY Pub Date : 2021-01-01 DOI: 10.5146/tjpath.2020.01509
Selma Erdoğan Düzcü, Zeliha Coşgun, Hesna Müzeyyen Astarci

Laryngeal chondrosarcoma is rare and accounts for 0.2% of all larynx malignancies. Although chondrosarcoma is the most common sarcoma seen in the larynx, laryngeal involvement by cartilage tumors is rare. In this article, we aimed to present the differential diagnosis of chondrosarcoma located in the thyroid cartilage, which is a rare site, in a 75-year-old male patient. The patient underwent total laryngectomy by the otolaryngology department. The macroscopy of the laryngectomy material sent to the pathology laboratory revealed a 3x2 cm tumor with a polypoid extension to the lumen from the bottom of the right vocal cord. Although clinical and radiological findings are important in the diagnosis, the definite diagnosis is based on the pathological examination. It is especially important to differentiate the lesion from chondromas.

喉软骨肉瘤是罕见的,占所有喉恶性肿瘤的0.2%。尽管软骨肉瘤是喉部最常见的肉瘤,但软骨肿瘤累及喉部的情况很少见。在这篇文章中,我们旨在提出一名75岁男性患者甲状腺软骨软骨肉瘤的鉴别诊断,这是一个罕见的部位。病人接受了耳鼻喉科的全喉切除术。送往病理实验室的喉切除术材料的宏观检查显示,有一个3x2厘米的肿瘤,从右声带底部延伸到管腔,呈息肉状。尽管临床和放射学表现在诊断中很重要,但明确的诊断是基于病理检查。区分病变和软骨瘤尤为重要。
{"title":"Laryngeal Chondrosarcoma of the Thyroid Cartilage.","authors":"Selma Erdoğan Düzcü,&nbsp;Zeliha Coşgun,&nbsp;Hesna Müzeyyen Astarci","doi":"10.5146/tjpath.2020.01509","DOIUrl":"10.5146/tjpath.2020.01509","url":null,"abstract":"<p><p>Laryngeal chondrosarcoma is rare and accounts for 0.2% of all larynx malignancies. Although chondrosarcoma is the most common sarcoma seen in the larynx, laryngeal involvement by cartilage tumors is rare. In this article, we aimed to present the differential diagnosis of chondrosarcoma located in the thyroid cartilage, which is a rare site, in a 75-year-old male patient. The patient underwent total laryngectomy by the otolaryngology department. The macroscopy of the laryngectomy material sent to the pathology laboratory revealed a 3x2 cm tumor with a polypoid extension to the lumen from the bottom of the right vocal cord. Although clinical and radiological findings are important in the diagnosis, the definite diagnosis is based on the pathological examination. It is especially important to differentiate the lesion from chondromas.</p>","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":"37 2","pages":"178-182"},"PeriodicalIF":1.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512689/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38458288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Turkish Journal of Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1